Literature DB >> 21263384

C-peptide ameliorates kidney injury following hemorrhagic shock.

Ranjit S Chima1, Giuseppe Maltese, Timberly Lamontagne, Giovanna Piraino, Alvin Denenberg, Michael O'Connor, Basilia Zingarelli.   

Abstract

Reperfusion injury following hemorrhagic shock is accompanied by the development of a systemic inflammatory state that may lead to organ failure. Insulin connecting peptide (C-peptide) has been shown to exert anti-inflammatory effects in sepsis and myocardial ischemia-reperfusion injury and to ameliorate renal dysfunction in diabetic animals. Hence, we investigated the effect of C-peptide on kidney injury after hemorrhagic shock. We hypothesized that C-peptide would exert renoprotective effects by blunting inflammation. Hemorrhagic shock was induced in male rats (3-4 months old) by withdrawing blood from the femoral artery to a mean arterial pressure of 50 mmHg. Animals were kept in shock for 3 h, at which time they were rapidly resuscitated by returning their shed blood. At the time of resuscitation and every hour thereafter, one group of animals received C-peptide (280 nmol/kg), whereas another group received vehicle. Hemorrhagic shock resulted in significant rise in plasma levels of creatinine and elevated kidney neutrophil infiltration as evaluated by myeloperoxidase activity in vehicle-treated rats in comparison with sham rats, thus suggesting kidney injury. Treatment with C-peptide significantly attenuated the rise in creatinine and kidney myeloperoxidase activity when compared with vehicle group. At a molecular level, these effects of C-peptide were associated with reduced expression of the c-Fos subunit and reduced activation of the proinflammatory kinases, extracellular signal-regulated kinase 1/2 (ERK 1/2), and c-Jun N-terminal kinase and subsequently reduced DNA binding of activator protein 1 in the kidney. Thus, our data suggest that C-peptide may exert renoprotective effects after hemorrhagic shock by modulating activator protein 1 signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21263384      PMCID: PMC3709434          DOI: 10.1097/SHK.0b013e31820b2e98

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  20 in total

Review 1.  Mammalian MAP kinase signalling cascades.

Authors:  L Chang; M Karin
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

2.  Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells.

Authors:  N M Al-Rasheed; F Meakin; E L Royal; A J Lewington; J Brown; G B Willars; N J Brunskill
Journal:  Diabetologia       Date:  2004-05-26       Impact factor: 10.122

Review 3.  C-peptide as a therapeutic tool in diabetic nephropathy.

Authors:  Claire E Hills; Nigel J Brunskill; Paul E Squires
Journal:  Am J Nephrol       Date:  2010-03-31       Impact factor: 3.754

4.  C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction.

Authors:  R Scalia; K M Coyle; B J Levine; G Booth; A M Lefer
Journal:  FASEB J       Date:  2000-11       Impact factor: 5.191

5.  Specific binding of proinsulin C-peptide to human cell membranes.

Authors:  R Rigler; A Pramanik; P Jonasson; G Kratz; O T Jansson; P Nygren; S Stâhl; K Ekberg; B Johansson; S Uhlén; M Uhlén; H Jörnvall; J Wahren
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

6.  C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion.

Authors:  L H Young; Y Ikeda; R Scalia; A M Lefer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-10       Impact factor: 4.733

Review 7.  Ischemic acute renal failure: an inflammatory disease?

Authors:  Joseph V Bonventre; Anna Zuk
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

Review 8.  Inflammatory cells in ischemic acute renal failure.

Authors:  John J Friedewald; Hamid Rabb
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

Review 9.  The innate immune response in ischemic acute kidney injury.

Authors:  Hye Ryoun Jang; Hamid Rabb
Journal:  Clin Immunol       Date:  2008-10-14       Impact factor: 3.969

10.  Insulin biosynthesis: evidence for a precursor.

Authors:  D F Steiner; D Cunningham; L Spigelman; B Aten
Journal:  Science       Date:  1967-08-11       Impact factor: 47.728

View more
  8 in total

1.  Renoprotective effects of C-peptide in the Dahl salt-sensitive rat.

Authors:  R Taylor Sawyer; Elizabeth R Flynn; Zachary M Hutchens; Jan M Williams; Michael R Garrett; Christine Maric-Bilkan
Journal:  Am J Physiol Renal Physiol       Date:  2012-07-18

2.  Resveratrol restores sirtuin 1 (SIRT1) activity and pyruvate dehydrogenase kinase 1 (PDK1) expression after hemorrhagic injury in a rat model.

Authors:  Bixi Jian; Shaolong Yang; Irshad H Chaudry; Raghavan Raju
Journal:  Mol Med       Date:  2014-03-13       Impact factor: 6.354

3.  C-peptide, a novel inhibitor of lung inflammation following hemorrhagic shock.

Authors:  Ranjit S Chima; Timberly LaMontagne; Giovanna Piraino; Paul W Hake; Alvin Denenberg; Basilia Zingarelli
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-03-11       Impact factor: 5.464

4.  Combined zinc supplementation with proinsulin C-peptide treatment decreases the inflammatory response and mortality in murine polymicrobial sepsis.

Authors:  Siarhei Slinko; Giovanna Piraino; Paul W Hake; John R Ledford; Michael O'Connor; Patrick Lahni; Patrick D Solan; Hector R Wong; Basilia Zingarelli
Journal:  Shock       Date:  2014-04       Impact factor: 3.454

Review 5.  Physiological effects and therapeutic potential of proinsulin C-peptide.

Authors:  Gina L C Yosten; Christine Maric-Bilkan; Patrizia Luppi; John Wahren
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-23       Impact factor: 4.310

6.  Minocycline and doxycycline, but not tetracycline, mitigate liver and kidney injury after hemorrhagic shock/resuscitation.

Authors:  Andaleb Kholmukhamedov; Christoph Czerny; Jiangting Hu; Justin Schwartz; Zhi Zhong; John J Lemasters
Journal:  Shock       Date:  2014-09       Impact factor: 3.454

Review 7.  C-peptide as a Therapy for Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  James A Shaw; Partha Shetty; Kevin D Burns; Dean Fergusson; Greg A Knoll
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

Review 8.  Biological Activity of c-Peptide in Microvascular Complications of Type 1 Diabetes-Time for Translational Studies or Back to the Basics?

Authors:  Aleksandra Ryk; Aleksandra Łosiewicz; Arkadiusz Michalak; Wojciech Fendler
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.